ACAD Competitors & Alternatives
Compare ACADIA Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ACAD
Main Stock$21.27
Tradestie Score
62
Market Cap
$3.58B
P/E Ratio
9.5
Revenue Growth
0.1%
Analyst Upside
+48.8%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$85.59
|
$3.91B | - | 57 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$17.73
|
$3.83B | - | 56 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$17.34
|
$3.68B | - | 49 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$101.00
|
$3.67B | - | 62 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.50
|
$3.59B | 12.1 | 57 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$253.25
|
$3.49B | 33.3 | 65 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$9.54
|
$3.40B | - | 56 | Compare |
|
QURE
uniQure N.V.
|
$27.87
|
$3.39B | - | 56 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$45.92
|
$3.33B | - | 51 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$30.60
|
$3.31B | - | 51 | Compare |
More ACAD Analysis
Data updated: Jun 16, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry